VXLLF (Vaxil Bio) E10: $-0.91 (As of Mar. 2026)


VXLLF Vaxil Bio Ltd VXLLF
38 GF Score
Price $0.02
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio E10?

Vaxil Bio VXLLF -85.27% 38 E10 is $-0.91 as of Mar. 2026. GuruFocus rates VXLLF with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vaxil Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.91 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 28.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vaxil Bio was 28.30% per year. The lowest was 27.80% per year. And the median was 28.05% per year.

As of today (2026-06-28), Vaxil Bio's current stock price is $0.0221. Vaxil Bio's E10 for the quarter that ended in Mar. 2026 was $-0.91. Vaxil Bio's Shiller PE Ratio of today is .


Vaxil Bio  (OTCPK:VXLLF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vaxil Bio E10 Related Terms


Vaxil Bio E10 Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio E10 Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.83 -6.27 -2.82 -2.48 -1.35

Vaxil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.45 -0.14 -0.67 -1.35 -0.91

VXLLF vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Vaxil Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Shiller PE Ratio falls into.


VXLLF
38GF Score
Vaxil Bio Ltd VXLLF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vaxil Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.02/132.2623*132.2623
=-0.020

Current CPI (Mar. 2026) = 132.2623.

Vaxil Bio Quarterly Data

per share eps CPI Adj_EPS
201606 -0.388 102.002 -0.503
201609 -0.381 101.765 -0.495
201612 -0.750 101.449 -0.978
201703 -0.373 102.634 -0.481
201706 -0.376 103.029 -0.483
201709 -0.407 103.345 -0.521
201712 -0.783 103.345 -1.002
201803 -0.121 105.004 -0.152
201806 -0.381 105.557 -0.477
201809 -0.384 105.636 -0.481
201812 0.000 105.399 0.000
201903 -0.106 106.979 -0.131
201906 -0.086 107.690 -0.106
201909 -0.088 107.611 -0.108
201912 0.000 107.769 0.000
202003 -0.068 107.927 -0.083
202006 -0.369 108.401 -0.450
202009 -0.378 108.164 -0.462
202012 0.000 108.559 0.000
202103 -0.077 110.298 -0.092
202106 -0.409 111.720 -0.484
202109 -0.069 112.905 -0.081
202112 -0.185 113.774 -0.215
202203 -0.036 117.646 -0.040
202206 -0.042 120.806 -0.046
202209 -0.038 120.648 -0.042
202212 -0.258 120.964 -0.282
202303 -0.365 122.702 -0.393
202306 -0.035 124.203 -0.037
202309 -0.008 125.230 -0.008
202312 0.002 125.072 0.002
202403 -0.015 126.258 -0.016
202406 0.000 127.522 0.000
202409 -0.013 127.285 -0.014
202412 -0.005 127.364 -0.005
202503 -0.018 129.181 -0.018
202506 0.015 129.892 0.015
202509 -0.007 130.287 -0.007
202512 0.146 130.366 0.148
202603 -0.020 132.262 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.91 mean?
Vaxil Bio (VXLLF) has a E10 of $-0.91 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vaxil Bio and its competitors.
Is Vaxil Bio's E10 too high?
Vaxil Bio's current E10 is $-0.91. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's E10 compare to VRTX and REGN?
Vaxil Bio's E10 of $-0.91 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vaxil Bio and its competitors. Vaxil Bio's current E10 is $-0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (VXLLF) has a current E10 of $-0.91. The current E10 is $-0.91. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vaxil Bio (VXLLF), the current E10 is $-0.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxil Bio Business Description

Other Exchanges VXL:Canada
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for VXLLF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price